Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
13
×
new york top stories
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
national top stories
clinical trials
raleigh-durham blog main
raleigh-durham top stories
wisconsin blog main
wisconsin top stories
deals
detroit blog main
detroit top stories
national
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
cancer
eli lilly
fda
indiana blog main
indiana top stories
startups
cancer immunotherapy
investing
medical device
medicare
merck
migraine
pfizer
What
companies
13
×
bio
life
drug
ipo
new
roundup
science
week
biotech
hasn’t
latest
street
wall
approval
big
biotechs
days
deal
fda
haul
ipos
leading
led
migraine
momentum
nash
news
pharmaceutical
price
public
raised
satsuma
sciences
slowed
springworks
startup
therapeutics
therapies
welcomed
Language
unset
Current search:
companies
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines